Exhibit 99.1 (b) 4

CONSOLIDATED STATEMENTS OF CASH FLOWS

NDCHealth Corporation and Subsidiaries

(In thousands)

	Year Ended
	May 30, 2003			May 31, 2002
Cash flows from operating activities:
Net income	$	30,602		$	15,110
Adjustments to reconcile net income to cash provided by operating activities:
Equity in losses of affiliated companies		1,348			2,064
Non-cash restructuring, impairment and other charges		2,283			—
Non-cash early extinguishment of debt charges		1,217			—
Depreciation and amortization		30,881			24,374
Deferred income taxes		19,365			(8,620	)
Provision for bad debts		1,678			1,619
Loss related to investments		14,455			41,000
Other, net		3,440			269
Changes in assets and liabilities which provided (used) cash, net of the effects of acquisitions:
Accounts receivable, net		(4,296	)		(6,429	)
Prepaid expenses and other assets		(17,732	)		(3,492	)
Accounts payable and accrued liabilities		(7,195	)		(1,973	)
Accrued interest on long term debt		12,269			161
Deferred revenue		14,426			636
Income taxes		827			(2,067	)
Net cash provided by operating activities		103,568			62,652
Cash flows from investing activities:
Capital expenditures		(44,791	)		(30,985	)
Business acquisitions, net of acquired cash		(116,146	)		(119,626	)
Investing activities and other non-current assets		(8,180	)		(14,310	)
Net cash used in investing activities		(169,117	)		(164,921	)
Cash flows from financing activities:
Net (repayments) borrowings under lines of credit		(91,000	)		91,000
Credit facility fee		—			(889	)
Net principal payments under capital lease arrangements and other long-term debt		(8,033	)		(2,371	)
Net cash from refinancing activities		168,006			—
Net issuances related to stock activities		4,634			6,559
Dividends paid		(5,568	)		(5,457	)
Net cash provided by financing activities		68,039			88,842
Cash flows from discontinued operations:
Cash provided by tax benefits of discontinued operations		6,106			21,233
Cash used in discontinued operations		(5,940	)		(6,779	)
Net cash provided by discontinued operations		166			14,454
Increase in cash and cash equivalents		2,656			1,027
Cash and cash equivalents, beginning of period		13,447			12,420
Cash and cash equivalents, end of period	$	16,103		$	13,447